Leading pharmaceutical companies in Norway 2018, by turnover

Unlike its Scandinavian neighbors, the key players in the Norwegian pharmaceutical market are not domestic companies, but rather branches of major international giants in the sector. As of 2018 the leading pharmaceutical company in Norway, in terms of turnover, was Pfizer AS. The company generated a turnover of almost 1.5 billion Norwegian kroner, and had a market share of 6.2 percent. Soon after followed MSD (Norge) AS, with a market share of six percent, and Novartis Norge AS, with a market share of 5.9 percent.

Pharmaceutical sales

   The value of pharmaceutical sales in Norway in 2017 was around 26.6 billion Norwegian kroner. The largest part of the pharmaceutical sales came from prescription pharmaceuticals. In particular, the group of pharmaceuticals that generated the largest turnover in 2017 was drugs for obstructive airway diseases, which had a turnover of around 1.2 billion Norwegian kroner.

Nonprescription pharmaceuticals

  The total turnover generated from nonprescription pharmaceuticals in Norway reached a value of around 1.4 billion Norwegian kroner, after several years of increasing turnover. That year, the leading nonprescription pharmaceutical company in Norway, by market share, was GSK Consumer Health, with a market share of 23.4 percent. It was followed by Karo Pharma AS, with a market share of 17.8 percent.

Leading pharmaceutical companies in Norway in 2018, by turnover

Turnover in million NOK
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2019

Region

Norway

Survey time period

2018

Special properties

top 15

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.